WallStreetZenWallStreetZen

NASDAQ: APLS
Apellis Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Apellis Pharmaceuticals earnings were $22.4M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest APLS earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$59.0M, down 127.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, APLS reported annual earnings of $22.4M, with -111.3% growth.

APLS earnings history

Current Revenue
$1.0B
Current Earnings
$22.4M
Current Profit Margin
2.2%

APLS Return on Equity

Current Company
8.2%
Current Industry
-31.4%
Current Market
28.9%
APLS's Return on Equity (8.2%)... subscribe to Premium to read more.
High Return on Equity Performance

APLS Return on Assets

Current Company
2.4%
Current Industry
-9.6%
APLS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when APLS announces earnings.

APLS Return on Capital Employed

Current Company
9.1%
Current Industry
-3.7%
APLS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

APLS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
APLS$70.00M$22.39MN/A$0.18
SRRK-$364.13M-$377.94MN/A-$3.29
PTCT$895.13M$682.64MN/A$8.58
TGTX$134.18M$447.18M+486.89%$3.10
SYRE-$155.22M-$155.20MN/A-$1.98
View Top Biotech Stocks

Apellis Pharmaceuticals Earnings Reports & History FAQ

What were Apellis Pharmaceuticals's earnings last quarter?

On APLS's earnings call on Invalid Date, Apellis Pharmaceuticals (NASDAQ: APLS) reported Q4 2025 earnings per share (EPS) of -$0.47, up 62.07% year over year. Total APLS earnings for the quarter were -$58.95 million. In the same quarter last year, Apellis Pharmaceuticals's earnings per share (EPS) was -$0.29.

If you're new to stock investing, here's how to buy Apellis Pharmaceuticals stock.

Is Apellis Pharmaceuticals profitable or losing money?

As of the last Apellis Pharmaceuticals earnings report, Apellis Pharmaceuticals is currently profitable. Apellis Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $22.39 million, a 111.31% decrease year over year.

What was APLS's earnings growth in the past year?

As of Apellis Pharmaceuticals's earnings date in Invalid Date, Apellis Pharmaceuticals's earnings has grown year over year. APLS earnings in the past year totalled $22.39 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.